Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-04

Clinical Trial Update: A Study of Ropivacaine Complex Methylene Blue Fascia Iliaca Compartment Block on Analgesia in Patients Undergoing Hip Arthroplasty [NA]

View source ↗

Summary

A completed clinical trial evaluating ropivacaine complex methylene blue fascia iliaca block for analgesia in hip arthroplasty, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLENE BLUE (METHYLENE BLUE)
  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: Wang wanxia | Conditions: Femoral Neck Disease | NA | Status: COMPLETED | Results posted: 2025-02-04